Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?

Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell? · Investor's Business Daily
ALLISON GATLIN
4 min read

In This Article:

Novavax stock remains volatile. After hitting a two-year high in June on enthusiasm for its updated Covid vaccine, shares have pulled back.

Recommended Stories